All In MedTech

FDA Clearance Tracker · P230020-S003

Altius Direct Electrical Nerve Stimulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 25, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 25, 2025

Approved

Time to decision

85 days

Received Apr 1, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P230020-S003
Device name
Altius Direct Electrical Nerve Stimulation System
Applicant location
Aliso Viejo, CA
Received
Apr 1, 2025
Decided
Jun 25, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P230020

Device type

Device class
Class III

Every decision under product code SAZ

FDA's approval statement

As written in FDA's record.

approval for a second battery charge current option of 100 mA, in addition to the battery charge current of 50 mA previously approved under the original PMA P230020.

Source documents

Other decisions for Neuros Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.